Literature DB >> 7795513

Transscleral suture fixation of posterior-chamber lenses after cataract extraction associated with vitreous loss.

H Mittelviefhaus1, H Witschel.   

Abstract

From 1987 to 1993, 21 patients who had undergone complicated cataract extraction that was associated with vitreous loss and transscleral suture fixation of the posterior-chamber lens (PC-IOL) in one eye (group A) and uncomplicated in-the-bag implantation of the PC-IOL in the fellow eye (group B) were followed prospectively. The follow-up period was 29.5 months (SD, +/- 17.0 months) in group A and 36.6 months (+/- 24.0 months) in group B. Visual acuity did not differ significantly between the two groups (P = 0.60, Wilcoxon test). In all, 17/21 patients in group A and 16/21 patients in group B achieved a visual acuity of > or = 20/40. Postoperative refractions measured in group A were +0.68 D more hyperopic than those measured in group B (P < 0.04). This result was consistent with the postoperative finding of a significantly deeper anterior chamber in group A (mean, 0.44 mm; P < 0.03). The accuracy of the desired postoperative refraction was poorer in group A. The risk for retinal detachment, cystoid macular edema, and intraocular pressure elevation was increased in patients who had had capsular defects and vitreous loss during cataract extraction. Nevertheless, transscleral suture fixation of PC-IOLs in patients with complicated cataract extractions associated with vitreous loss can give acceptable visual results. We recommend that +0.5 D be added to the calculated IOL power when severe complications require transscleral suture fixation of the PC-IOL during cataract extraction.

Entities:  

Mesh:

Year:  1995        PMID: 7795513

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  1 in total

1.  Secondary IOL Implantation without Capsular Support: A Laser Flare Cell Meter Study.

Authors:  Mauro Cellini; Ernesto Strobbe; Pier Giorgio Toschi; Emilio C Campos
Journal:  ISRN Ophthalmol       Date:  2012-01-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.